Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Cell & Bioscience

Fig. 2

From: MAP4K4: an emerging therapeutic target in cancer

Fig. 2

Schematic diagram of suggested MAP4K4 downstream effectors and biological outcomes in cancer. Studies on MAP4K4 in cancer have shown that MAP4K4 regulates different biological outcomes (red boxes) trough different cell signaling pathways (boxes with different colors), implicating that MAP4K4 exerts its role in regulation of tumorigenesis and tumor progression in a biological context-dependent manner

Back to article page